| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity | 4.96e-06 | 6 | 12 | 2 | GO:0047238 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 9.22e-05 | 153 | 12 | 3 | GO:0008194 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.95e-04 | 35 | 12 | 2 | GO:0015020 | |
| GeneOntologyMolecularFunction | acetylgalactosaminyltransferase activity | 1.95e-04 | 35 | 12 | 2 | GO:0008376 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 5.93e-04 | 288 | 12 | 3 | GO:0016757 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 6.84e-03 | 211 | 12 | 2 | GO:0016758 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 9.54e-03 | 766 | 12 | 3 | GO:0016491 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 3.91e-05 | 357 | 12 | 4 | GO:0009101 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate biosynthetic process | 5.86e-05 | 20 | 12 | 2 | GO:0030206 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | 8.07e-05 | 430 | 12 | 4 | GO:0009100 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate proteoglycan biosynthetic process | 1.00e-04 | 26 | 12 | 2 | GO:0050650 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate metabolic process | 1.25e-04 | 29 | 12 | 2 | GO:0030204 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate proteoglycan metabolic process | 1.83e-04 | 35 | 12 | 2 | GO:0050654 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | 4.10e-04 | 1226 | 12 | 5 | GO:1901135 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | 6.33e-04 | 736 | 12 | 4 | GO:1901137 | |
| GeneOntologyBiologicalProcess | proteoglycan biosynthetic process | 7.33e-04 | 70 | 12 | 2 | GO:0030166 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan biosynthetic process | 8.63e-04 | 76 | 12 | 2 | GO:0006024 | |
| GeneOntologyBiologicalProcess | aminoglycan biosynthetic process | 9.56e-04 | 80 | 12 | 2 | GO:0006023 | |
| GeneOntologyBiologicalProcess | proteoglycan metabolic process | 1.40e-03 | 97 | 12 | 2 | GO:0006029 | |
| GeneOntologyBiologicalProcess | mucopolysaccharide metabolic process | 1.49e-03 | 100 | 12 | 2 | GO:1903510 | |
| GeneOntologyCellularComponent | Golgi membrane | 5.57e-04 | 721 | 12 | 4 | GO:0000139 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 1.28e-03 | 94 | 12 | 2 | GO:0032580 | |
| HumanPheno | Clinodactyly of the 2nd finger | 4.15e-05 | 9 | 6 | 2 | HP:0040022 | |
| MousePheno | short limbs | 5.61e-05 | 111 | 10 | 3 | MP:0000547 | |
| MousePheno | proportional dwarf | 1.26e-04 | 24 | 10 | 2 | MP:0008974 | |
| Domain | Chond_GalNAc | 1.06e-05 | 8 | 12 | 2 | IPR008428 | |
| Domain | CHGN | 1.06e-05 | 8 | 12 | 2 | PF05679 | |
| Domain | - | 1.19e-03 | 81 | 12 | 2 | 3.90.550.10 | |
| Domain | Nucleotide-diphossugar_trans | 1.40e-03 | 88 | 12 | 2 | IPR029044 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CHONDROITIN_SULFATE_BIOSYNTHESIS | 1.01e-05 | 8 | 9 | 2 | M47920 | |
| Pathway | WP_PROTEOGLYCAN_BIOSYNTHESIS | 5.51e-05 | 18 | 9 | 2 | M39865 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | 6.16e-05 | 19 | 9 | 2 | MM14800 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | 6.84e-05 | 20 | 9 | 2 | M658 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE | 8.31e-05 | 22 | 9 | 2 | M19166 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS | 2.93e-04 | 41 | 9 | 2 | M48095 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 4.03e-04 | 48 | 9 | 2 | MM14696 | |
| Pathway | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | 4.37e-04 | 50 | 9 | 2 | M678 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 2.61e-03 | 123 | 9 | 2 | MM14623 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 2.74e-03 | 126 | 9 | 2 | M695 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.21e-02 | 271 | 9 | 2 | MM15406 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.36e-02 | 288 | 9 | 2 | M16864 | |
| Pubmed | 1.09e-07 | 2 | 12 | 2 | 23811343 | ||
| Pubmed | Molecular cloning and expression of a human chondroitin synthase. | 1.09e-07 | 2 | 12 | 2 | 11514575 | |
| Pubmed | 3.27e-07 | 3 | 12 | 2 | 25568321 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 1.29e-06 | 1201 | 12 | 6 | 35696571 | |
| Pubmed | 2.29e-06 | 7 | 12 | 2 | 17145758 | ||
| Pubmed | 3.05e-06 | 8 | 12 | 2 | 6781479 | ||
| Pubmed | 7.19e-06 | 12 | 12 | 2 | 29287114 | ||
| Pubmed | Chondroitin sulfate synthase 1 (Chsy1) is required for bone development and digit patterning. | 1.48e-05 | 17 | 12 | 2 | 22280990 | |
| Pubmed | Genome-wide association study of antibody response to smallpox vaccine. | 6.08e-05 | 34 | 12 | 2 | 22542470 | |
| Pubmed | 7.22e-05 | 37 | 12 | 2 | 32201365 | ||
| GeneFamily | Beta 4-glycosyltransferases | 2.32e-05 | 17 | 8 | 2 | 425 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.02e-04 | 168 | 12 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#3_top-relative-expression-ranked_200 | 1.53e-04 | 33 | 12 | 2 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k3_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_500 | 1.93e-04 | 37 | 12 | 2 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_500 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-06 | 162 | 12 | 3 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-06 | 162 | 12 | 3 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-06 | 162 | 12 | 3 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 1.14e-05 | 170 | 12 | 3 | 151dabe1d240dde414c881bf4fa816c69fa1c32d | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 1.18e-05 | 172 | 12 | 3 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | IPF-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.56e-05 | 189 | 12 | 3 | ad7bb3a7de8e48c145e4382f90d30bb2159c2b76 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.71e-05 | 195 | 12 | 3 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.12e-04 | 127 | 12 | 2 | fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Esophagus_normal_tissue-Esophagus_normal_tissue-2|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 5.37e-04 | 130 | 12 | 2 | 3450b9edc7360f8494b5e2ded3132c508bbc971b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.70e-04 | 134 | 12 | 2 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.87e-04 | 136 | 12 | 2 | 1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.32e-04 | 152 | 12 | 2 | 595afcfa8b161e291fcaf2afc7336bac9b6fae0f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.32e-04 | 152 | 12 | 2 | ee329249a034a969a16b26a224aa04249d67382d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.32e-04 | 152 | 12 | 2 | bd1f36b436d8ab7dd8420f595b97d851eab31a38 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Poorly_Differentiated_or_Epithelioid_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 7.32e-04 | 152 | 12 | 2 | 6f9c343669883618cd9c1c8921a90c34d153f303 | |
| ToppCell | Adult-Immune-B_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.61e-04 | 155 | 12 | 2 | 5857aebd43b901fc9f8c46f2d628582969db9e6a | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.61e-04 | 155 | 12 | 2 | 216a240bfb82cdefc59e2f342689dbaaacb7c184 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 7.80e-04 | 157 | 12 | 2 | 6ce7f2ea613e7f8e771860e8c0512274e4f54369 | |
| ToppCell | ASK440-Immune-B_cell|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.00e-04 | 159 | 12 | 2 | d31eb59c1b5948df721b829b9a7e806f27cbd41c | |
| ToppCell | Healthy/Control-Treg|Healthy/Control / Disease group and Cell class | 8.00e-04 | 159 | 12 | 2 | 16a322760c99f3e2c3b73cbb399f77868951d3cb | |
| ToppCell | Healthy/Control-Treg|World / Disease group and Cell class | 8.20e-04 | 161 | 12 | 2 | 457297cda5c9cee3bcc069fdecbbe24def027e5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-04 | 164 | 12 | 2 | 43630a448f4369fa9e4e3eccdf3b9f29cec16c39 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal--glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-04 | 164 | 12 | 2 | 46208f18325976c89f572f6627aea0582142b92d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-04 | 164 | 12 | 2 | 108fbecb56d69a675d6ce6e826a873ae528f2fd7 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.61e-04 | 165 | 12 | 2 | 21a82a975f550080b6674750b06212205cd16742 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.61e-04 | 165 | 12 | 2 | 9ccce713d4122054bf4bef4a7126d90cf9141b84 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.61e-04 | 165 | 12 | 2 | 8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.61e-04 | 165 | 12 | 2 | dbe231d00843cae917efd1abea6079ace3b45cdf | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.93e-04 | 168 | 12 | 2 | 9e7b4b9b977e90e083f5164013e79df8bc2d492e | |
| ToppCell | CTRL-Myeloid-Monocyte|CTRL / Disease state, Lineage and Cell class | 8.93e-04 | 168 | 12 | 2 | 13dca90c7b811e4d5e8fa44f5e892e29be9787a6 | |
| ToppCell | ASK440-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.93e-04 | 168 | 12 | 2 | 127559d1a083c68cda9fce143afcc3eec168df17 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.93e-04 | 168 | 12 | 2 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.93e-04 | 168 | 12 | 2 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.93e-04 | 168 | 12 | 2 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.14e-04 | 170 | 12 | 2 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.14e-04 | 170 | 12 | 2 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.14e-04 | 170 | 12 | 2 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.14e-04 | 170 | 12 | 2 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | Adult-Immune-B_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.24e-04 | 171 | 12 | 2 | 355a246f3395900342d400f6f7c6640cba0d4d5d | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-04 | 174 | 12 | 2 | 268be5e7d2a18b866770b7cdb966c3958c7e6534 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-04 | 174 | 12 | 2 | 4cdf2eedc28d88d18241ee390092426fdf849e79 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-04 | 174 | 12 | 2 | 3f4277763e312b46ebd4401ea4a2f5d4c850c768 | |
| ToppCell | Healthy_donor-Treg|World / disease group, cell group and cell class (v2) | 9.57e-04 | 174 | 12 | 2 | dc3b06420b0ad9c7060571e7bf5714e028d598bf | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.57e-04 | 174 | 12 | 2 | fad66d1a8407574b6a835e0bdb824a53afa58650 | |
| ToppCell | Healthy_donor-Treg|Healthy_donor / disease group, cell group and cell class (v2) | 9.57e-04 | 174 | 12 | 2 | 1d76921c8404b5be5fbe9f3157d53578033f2ad2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.68e-04 | 175 | 12 | 2 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.68e-04 | 175 | 12 | 2 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.68e-04 | 175 | 12 | 2 | 28b29f844fa46fe579ddc19039fb2d9dc5f48f3b | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.68e-04 | 175 | 12 | 2 | ac96ca9ca309b0d72a2f5af6a3b02c7f80755750 | |
| ToppCell | Adult-Immune-B_cell|Adult / Lineage, Cell type, age group and donor | 9.79e-04 | 176 | 12 | 2 | 4aa00dcde907ad83d3aa4bb10439b7b5c4be1e5d | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.90e-04 | 177 | 12 | 2 | c82332c5f656aa26513e4f7525d5d4d733019725 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.90e-04 | 177 | 12 | 2 | 8a955a7ab84c434f9ad4b467246b8be3cb479406 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.90e-04 | 177 | 12 | 2 | a58c93be9767e3fe8fbb6b0db1210d3a33aac662 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.90e-04 | 177 | 12 | 2 | 3ed383e5c0b15d9d5e75b98cf6d10609f48fc422 | |
| ToppCell | LPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.90e-04 | 177 | 12 | 2 | 5ed65e08d773d157840317c72e0d43c261d438d4 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-03 | 179 | 12 | 2 | 8f7d2730188f67e8ca290c60ba171fc13e0cf69e | |
| ToppCell | COPD-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 1.01e-03 | 179 | 12 | 2 | e816dd846a6918ec143b57a380c3a47ed073b66e | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts|Lung / Manually curated celltypes from each tissue | 1.01e-03 | 179 | 12 | 2 | 3fa75eec3e86fd1797eaa33362257df7f9b2a0bf | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-03 | 181 | 12 | 2 | 97022416d0f5a5ba9c9bd5e70ce95cf4cb19af89 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-03 | 182 | 12 | 2 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| ToppCell | control-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.05e-03 | 182 | 12 | 2 | 8e96a9dd70814cb0925776613b3a12026d455cad | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-03 | 182 | 12 | 2 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 183 | 12 | 2 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 183 | 12 | 2 | 85b2335fa938a94e74251bd8d99de1bd21265ac9 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-plasma_cell-plasma_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-03 | 183 | 12 | 2 | 0f6799e4f058bed546fe5759502430f4a19635da | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-plasma_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-03 | 183 | 12 | 2 | 8ef5223e46f1fd81a856261248cc77e7c7e72ef6 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 183 | 12 | 2 | 6eeef55071ae25a61616df4fcfb2cea560aa7923 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 183 | 12 | 2 | 0513bb73552bfee609877d924fa97684200f595c | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 183 | 12 | 2 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 183 | 12 | 2 | 4c325ee6da070513097a11445ec95b0415ffd8a2 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 183 | 12 | 2 | bc24145855bf4d027a8058bf92bc796c10f241bb | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.07e-03 | 184 | 12 | 2 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 1.07e-03 | 184 | 12 | 2 | 0299cd30a3ea8e861a9d529043c204048ae21d29 | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.07e-03 | 184 | 12 | 2 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-03 | 184 | 12 | 2 | 42cadfdb5d29a50bd7e901ddd14d42b39e8474f0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-03 | 184 | 12 | 2 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | remission-CD8+_T_naive|remission / disease stage, cell group and cell class | 1.07e-03 | 184 | 12 | 2 | fe20fa4457d4a4a75689978275b0afb5f6243faf | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.08e-03 | 185 | 12 | 2 | 863a3d44c1f115942d7a2a2b63a92fe5fc768814 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-03 | 185 | 12 | 2 | 27dbfcd40ec832d5cf757331d8af3b5176ae90fb | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 185 | 12 | 2 | 238938a4682b44e88a30b86b13af4feeabe9553d | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-03 | 185 | 12 | 2 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.08e-03 | 185 | 12 | 2 | 1c23891e4d75f99296d1304af7a9d6c3cb28d04c | |
| ToppCell | COVID-19_Convalescent-CD8+_T_naive|COVID-19_Convalescent / Disease condition and Cell class | 1.08e-03 | 185 | 12 | 2 | 2f8277a0b58fb0c49fa76ff6dfa6da961da1f9f5 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-03 | 185 | 12 | 2 | ca8e921a6b45cd39474b9f86c95e7be023585c5d | |
| ToppCell | saliva-Severe-critical_progression_d28-40|saliva / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.09e-03 | 186 | 12 | 2 | 0095560ca776b01aa473ad4d6015ed78fc93ff51 | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 1.10e-03 | 187 | 12 | 2 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-03 | 187 | 12 | 2 | 173f029dcf32af008f517912f6d110a33a9e98cf | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-03 | 187 | 12 | 2 | 9fdfca5b70f585843ef9d810154674a8e561e765 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-03 | 187 | 12 | 2 | a525753a8a908ee1ef0b8f06e68855e4af27bf86 | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.10e-03 | 187 | 12 | 2 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | Healthy_donor-B_memory|World / disease group, cell group and cell class (v2) | 1.10e-03 | 187 | 12 | 2 | 4f68e3243071a4549c80aff8bff32c6ad892ee7f | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-Treg|COVID-19_Mild / Disease group, lineage and cell class | 1.12e-03 | 188 | 12 | 2 | 42553fdc127e5f613ffd5067620a768a40f1a8a1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.12e-03 | 188 | 12 | 2 | 72be6fe654f3a5f654d3b9680145bce7ae9b721d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.12e-03 | 188 | 12 | 2 | 9db3d3010cb8a1f3ee1cdccaf3cbaac3cf983fc5 | |
| ToppCell | Control-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.12e-03 | 188 | 12 | 2 | 47126c371a242c937499fd278a74a882df8f759c | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 188 | 12 | 2 | 70184b14160b71a1fecd7f195e5a16c5937738a2 | |
| ToppCell | background-B_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.12e-03 | 188 | 12 | 2 | 9acb7a95e3095f15918a5d094107d1d565a42842 | |
| ToppCell | Non-neuronal-Non-dividing-OPC|World / Primary Cells by Cluster | 1.13e-03 | 189 | 12 | 2 | 13848a031ab896b4b24c8319e4745b9b17ff9cfd | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 1.13e-03 | 189 | 12 | 2 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC|World / Primary Cells by Cluster | 1.13e-03 | 189 | 12 | 2 | ddf5be73912570c32c50f4ac2902da9b590526f8 | |
| Disease | response to vaccine | 1.48e-05 | 122 | 12 | 3 | EFO_0004645 | |
| Disease | eosinophil measurement | 8.55e-04 | 108 | 12 | 2 | EFO_0803540 | |
| Disease | bone fracture | 9.19e-04 | 112 | 12 | 2 | EFO_0003931 | |
| Disease | RS-6-hydroxywarfarin measurement | 1.75e-03 | 155 | 12 | 2 | EFO_0803328 | |
| Disease | dyslexia | 1.91e-03 | 162 | 12 | 2 | EFO_0005424 | |
| Disease | response to xenobiotic stimulus | 2.40e-03 | 182 | 12 | 2 | GO_0009410 | |
| Disease | refractive error, age at onset, Myopia | 2.69e-03 | 193 | 12 | 2 | EFO_0004847, HP_0000545, MONDO_0004892 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFYPVLFSQYNPGII | 381 | Q8TDX6 | |
| YGPVFTVYFGMNPIV | 61 | P10632 | |
| IYYFLEDVFPNQPGG | 181 | Q96Q80 | |
| YVYPQAFVQPGVVIP | 121 | Q9BX46 | |
| YAFLYGVFPVAPGVA | 316 | Q7Z3F1 | |
| QPYITQNYFPVGTVV | 111 | P08174 | |
| FVYGSFVQQGGEVPY | 611 | O43424 | |
| GILVNNVGVFYPYPQ | 146 | Q3SXM5 | |
| QYSFITGPAVIPGYF | 141 | Q9Y2B1 | |
| VDAFPPNGYGLYNIV | 281 | Q8NBK3 | |
| GQQIYFPIIFSQYDP | 651 | Q86X52 | |
| VFTYQVFGVGVPNPY | 196 | Q92545 |